28/08/07
Despite being curable, TB continues to kill nearly 2 million people a year. Globally TB-HIV and Multi-Drug Resistant Tuberculosis (MDR) are two of the most serious challenges confronting TB control efforts. These two issue areas also serve to highlight some of the biggest shortcomings of current TB prevention, diagnostic, and treatment tools in general. The lack of TB patient participation, community advocacy and political will that is needed to push for them are the root causes of unacceptably high death rates for persons living with MDR and TB-HIV. The challenges of low rates of TB detection and treatment completion are also issues that riddle TB programs in general.
One of the most important bodies to develop a multi-sectoral coordinated effort for TB control in the European and Central Asian region is a coalition of various public and private sector stakeholders called the Stop TB Partnership for Europe (The Partnership). The Partnership is made up of more than 30 organizations including research institutions, foundations, National TB Programs, product developers, and community activists. It is an independent organization, and has its secretariat based at the International Federation of the Red Cross, Geneva. Through this important Partnership, patient and community activists can influence policy formulation, its implementation, and evaluation for global TB control. This is a call for nominations to fill existing vacancies for two community advocate seats on the Stop TB Partnership for Europe Executive Committee.
The Executive Committee of the Partnership has worked on enhancing community involvement in TB advocacy and has created two community seats on the Stop TB Partnership for Europe Executive Committee.
Please read through the following
frequently asked questions to ascertain if you are a good fit for this
important role in the fight to reduce TB. We are currently seeking nominations
for two positions for the Executive Committee.
Due the high burden of TB in
East Europe & Central Asia and the complexities of HIV, TB &
MDR-TB and drug use, which is a major factor, particularly in Russia
& Ukraine, at least one of the two seats on the Executive Committee
of the Stop TB Partnership for Europe has been reserved for a community
member from EE&CAR. This person should be able to represent or have
a knowledge of the region & its complexities.
Sincerely,
Mick Matthews
Chair
Stop-TB Partnership for Europe
Executive Committee
TB and or HIV activist are encouraged to apply, especially if they have:
1. The capacity to commit adequate time to the CB or WG activities
2. Access to adequate staff or community support to carry out duties assigned as board members.
3. A record of effective advocacy work in the affected communities
4. A record of participation in community-based advocacy networks
5. The ability to participate in CB / WG meetings, activities and task forces
6. The applicant must have
had TB.
How Can I Apply?
By 07/09/2007 please send the following information to
Terry White, ECUO and All-Ukranian Network (twhite@network.org.ua)
1) A letter of interest stating whether you are applying to participate. Making reference to how you fit the above roles and responsibilities and your specific experience with the topic. (Explain in 400-500 words only)
2) Your resume/CV. (Please include a jpeg photo of yourself)
3) Contact information/email
addresses for 2 references that can vouch for your activist work in
relation to TB and/ or HIV.
- Find out more...
Frequently Asked Questions
- Translate this article to Russian
